Interstitial Photodynamic Therapy (PDT) for the Treatment of Patients with Locally Advanced or Recurrent Head and Neck Cancer - Poll - MDSpire

Interstitial Photodynamic Therapy (PDT) for the Treatment of Patients with Locally Advanced or Recurrent Head and Neck Cancer

An NCI/NIH funded Phase 1/2 clinical study (NCT03727061) will evaluate the safety and efficacy of adjuvant Photofrin® mediated I-PDT in patients with locally advanced or recurrent HNC who failed to respond to standard therapy and are not amenable to standard curative treatment.

  • August 5, 2019

Share

Original Source(s)

Interstitial Photodynamic Therapy (PDT) for the Treatment of Patients with Locally Advanced or Recurrent Head and Neck Cancer

  • August 5, 2019

Related Content

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Real-world healthcare resource use and costs associated with the management of locally advanced head and neck cancer in Portugal – TRACE2 study

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study